Skip to main content

Table 1 GP prevents HFD-induced hyperlipidemia

From: Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats

 

TC (mmol/L)

TG (mmol/L)

LDL-C (mmol/L)

HDL-C (mmol/L)

NAFLD

2.14 ± 0.26

0.63 ± 0.04

1.61 ± 0.10

0.32 ± 0.17

Control

1.26 ± 0.24**

0.50 ± 0.07**

1.26 ± 0.34*

0.47 ± 0.15**

DLPC

1.98 ± 0.62

0.51 ± 0.08*

1.15 ± 0.25**

0.47 ± 0.21*

GPL

1.87 ± 0.33

0.48 ± 0.07**

1.14 ± 0.21**

0.39 ± 0.12

GPM

1.69 ± 0.28*

0.48 ± 0.07**

1.16 ± 0.36**

0.51 ± 0.08**

GPH

1.29 ± 0.27**

0.49 ± 0.16**

1.14 ± 0.24**

0.54 ± 0.09**

  1. Serum concentrations of TC, TG, LDL-C and HDL-C in each group compared with NAFLD group (n = 10 for each group). Data are shown as mean ± standard deviation. Whereas * and ** represent statistically significant results (P < 0.05, P < 0.01, respectively) based on Newman–Keuls post hoc one-way ANOVA analysis. GPL: low dose of GP treatment; GPM: middle dose of GP treatment; GPH: high dose of GP treatment